Duo Oncology Inc.

Pittsburgh, PA Duo Oncology

UEI
QK2QNS6KHHM5
CAGE
8TFL4
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2403 Sidney St #255, Pittsburgh, PA 15203, USA
Website
duooncology.com
Founded
2020
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Duo Oncology Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Stroma-penetrating nanomedicine to improve treatment for pancreatic cancer - project summary annually, pancreatic cancer… Grant · R41CA278033 National Cancer Institute $399,970
A novel dual-carrier ultrasmall nanomedicine for the treatment of stroma-rich pancreatic cancer - abstract pancreatic… Grant · R41CA285174 National Cancer Institute $844,934

Quick answers

What is Duo Oncology Inc.'s UEI?

Duo Oncology Inc.'s Unique Entity ID (UEI) in SAM.gov is QK2QNS6KHHM5.

What is Duo Oncology Inc.'s CAGE code?

Duo Oncology Inc.'s CAGE code is 8TFL4.

What is Duo Oncology Inc.'s primary NAICS code?

Duo Oncology Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).

Where is Duo Oncology Inc. located?

Duo Oncology Inc.'s physical address in SAM.gov is 2403 Sidney St #255, Pittsburgh, PA 15203, USA.

Is Duo Oncology Inc. registered in SAM.gov?

Yes. Duo Oncology Inc.'s SAM.gov registration is active through December 4, 2026.

What is Duo Oncology Inc.'s most recent federal award?

Duo Oncology Inc.'s most recent federal grant award is Stroma-penetrating nanomedicine to improve treatment for pancreatic cancer - project summary annually, pancreatic cancer… (R41CA278033), from National Cancer Institute, on August 15, 2024.

On GovTribe

See Duo Oncology Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login